JBIO (Aerovate Therapeutics Inc) Pangali Forward P/E

Logo korporat perusahaan Aerovate Therapeutics, Inc. (JBIO)

This price visualization assisting in the basic asset valuation for Aerovate Therapeutics Inc (JBIO) demonstrates a P/E multiple of 0.00. Aerovate Therapeutics Inc specializes in developing drugs to treat pulmonary hypertension. The business model is based on global sales with low production costs following certification. Stability is ensured by a patent for an inhalational agent (Phase 2b) and a unique dry powder technology, which creates a barrier for competitors.

Prakiraan rega marang bathi: aerovatetx.com (JBIO) kanggo 30.04.2025 - 18.11.2026

Rincian analitis perusahaan Aerovate Therapeutics Inc

Ringkesan analitik perusahaan:Aerovate Therapeutics
Sampel barang Aerovate Therapeutics Inc

The metric is calculated as the ratio of the current market value of Aerovate Therapeutics Inc (JBIO) to the projected earnings per share. This coefficient determines market expectations regarding future business efficiency. For Aerovate Therapeutics Inc, such a valuation depends directly on the success of joint developments of inhalation agents and the potential for M&A transactions. Analyzing the company's expected P/E multiple allows for the identification of asset overboughtness. The price action of the company's expected P/E multiple helps determine a fair entry price.

Pesaing Aerovate Therapeutics Inc (JBIO)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Kiniksa Corp (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols, S.A.|Prakiraan rega marang bathi ADPT|Pangali Forward P/E celldex.com|Rega marang bathi mangsa ngarep Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (veratx.com)|Dianthus Pharma (DNTH) - Rasio prakiraan rega marang bathi|PHVS - Rega marang bathi mangsa ngarep|ABCL - Pangali Forward P/E|Tourmaline (TRML) - Rega marang bathi mangsa ngarep|Precigen - Pangali mangsa ngarep rega marang bathi|PHAR (Pharming Group NV) - Pangali Forward P/E|Pangali Forward P/E Nektar Therapeutics|Rega marang bathi mangsa ngarep Upstream Bio Inc (UPB)|Pangali Forward P/E zenasbio.com (ZBIO)|Rega marang bathi mangsa ngarep Immunome Corp IMNM|Pangali Forward P/E Gossamer Bio Inc GOSS|KALV - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prakiraan rega marang bathi|Savara Inc. - Pangali mangsa ngarep rega marang bathi|RIGL (Rigel Pharmaceuticals, Inc.) - Pangali Forward P/E|Rega marang bathi mangsa ngarep ANAB|Pangali Forward P/E ATXS|ENGN - Rasio prakiraan rega marang bathi|Pangali Forward P/E RAPT (rapt.com)|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi